TNFRSF8 and lymphoma: BV sensitivity of eIMS cells was compared to MRC-5 fibroblasts (CD30 negative, Supplementary Fig. 2) and Karpas299 lymphoma cells (CD30 positive48) as negative and positive controls, respectively.